FDA Recommends Labeling Update for Laparoscopic Power Morcellators

The FDA has issued a final guidance recommending that devicemakers include more specific information in the labeling of laparoscopic power morcellators (LPMs) on the risk of spreading benign uterine tissue and on the use of LPM containment systems.
Source: The GMP Letter